Answers are grounded in this paper and cite their sources.
Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.
No takes yet. Share an insight, caveat, or question.
Strouse et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: